Skip to main content
Top
Published in: Journal of Cancer Survivorship 3/2022

21-04-2022 | Brain Tumor | Editorial

“It’s always something”: the health and functional complexities of late effects in long-term cancer survivors

Author: Michael Feuerstein

Published in: Journal of Cancer Survivorship | Issue 3/2022

Login to get access

Excerpt

As most of you are well aware by now, I was diagnosed with a malignant brain tumor at the age of 53, 19 years ago in 2003. I am thankful for the life I have been given, but I did feel the need to write this editorial in an effort to remind those involved in research and practice that some late effects in long-term cancer survivors are indeed complex. Learning more about these complexities will influence both physical and functional health and is essential for optimal long-term survivorship. Sure, exacerbation of these late effects may in part be the consequence of aging, but nevertheless, their longer-term impact and the need for effective solutions remain an enigma. …
Metadata
Title
“It’s always something”: the health and functional complexities of late effects in long-term cancer survivors
Author
Michael Feuerstein
Publication date
21-04-2022
Publisher
Springer US
Keyword
Brain Tumor
Published in
Journal of Cancer Survivorship / Issue 3/2022
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-022-01208-w

Other articles of this Issue 3/2022

Journal of Cancer Survivorship 3/2022 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine